We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$9.85B
AUM Growth
+$544M
Cap. Flow
+$305M
Cap. Flow %
3.1%
Top 10 Hldgs %
10.6%
Holding
1,507
New
131
Increased
296
Reduced
233
Closed
100

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$69.7M
2
WBA
Walgreens Boots Alliance
WBA
+$62.8M
3
EXR icon
Extra Space Storage
EXR
+$62.1M
4
APC
Anadarko Petroleum
APC
+$58.4M
5
CI icon
Cigna
CI
+$58.3M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$70.2M
2
SRE icon
Sempra
SRE
+$62.5M
3
LNC icon
Lincoln National
LNC
+$62.2M
4
XL
XL Group Ltd.
XL
+$60.6M
5
NEE icon
NextEra Energy
NEE
+$58.5M

Sector Composition

Rank Sector Weight
1 Financials 23.55%
2 Industrials 12.89%
3 Consumer Discretionary 12.47%
4 Healthcare 10.29%
5 Technology 10.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CZR icon
1426
Caesars Entertainment
CZR
$6.06B
– –
-30,000
Closed -$990K
DD icon
1427
DuPont de Nemours
DD
$18.5B
– –
-290,315
Closed -$46.8M
DE icon
1428
Deere & Co
DE
$160B
– –
-268,000
Closed -$41.6M
FATE icon
1429
Fate Therapeutics
FATE
$286M
– –
-202,000
Closed -$1.97M
FC icon
1430
Franklin Covey
FC
$242M
– –
-33,334
Closed -$897K
CBIO
1431
Crescent Biopharma
CBIO
$535M
– –
-200
Closed -$325K
HFWA icon
1432
Heritage Financial
HFWA
$1.22B
– –
-110,362
Closed -$3.38M
IBP icon
1433
Installed Building Products
IBP
$6.01B
– –
-10,100
Closed -$607K
INVE icon
1434
Identive
INVE
$63.4M
– –
-20,200
Closed -$76K
ISRG icon
1435
Intuitive Surgical
ISRG
$127B
– –
-23,160
Closed -$3.19M
KURA icon
1436
Kura Oncology
KURA
$800M
– –
-18,000
Closed -$338K
LNC icon
1437
Lincoln National
LNC
$8.72B
– –
-851,850
Closed -$62.2M
MPWR icon
1438
Monolithic Power Systems
MPWR
$70.1B
– –
-3,000
Closed -$347K
MRAM icon
1439
Everspin Technologies
MRAM
$341M
– –
-44,000
Closed -$332K
MTNB icon
1440
Matinas BioPharma
MTNB
$1.88M
– –
-3,780
Closed -$145K
NEE icon
1441
NextEra Energy
NEE
$181B
– –
-1,431,600
Closed -$58.5M
NTWK icon
1442
NetSol Technologies
NTWK
$51.2M
– –
-37,680
Closed -$173K
NVR icon
1443
NVR
NVR
$16.5B
– –
-3,490
Closed -$9.77M
OTLK icon
1444
Outlook Therapeutics
OTLK
$183M
– –
-863
Closed -$123K
PCH
1445
DELISTED
PotlatchDeltic
PCH
– –
-7,600
Closed -$396K
PDSB icon
1446
PDS Biotechnology
PDSB
$38.4M
– –
-4,360
Closed -$103K
PULM icon
1447
Pulmatrix
PULM
$6.35M
– –
-500
Closed -$51K
PYPL icon
1448
PayPal
PYPL
$48.9B
– –
-64,400
Closed -$4.89M
RCL icon
1449
Royal Caribbean
RCL
$85.1B
– –
-207,700
Closed -$24.5M
RDNT icon
1450
RadNet
RDNT
$5.02B
– –
-55,900
Closed -$805K
56 57
58
59 60

Similar funds

CFC
Cincinnati Financial Corp Fairfield, Ohio $4.96B AUM 18.21% 1-Year Est. Return
SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return

Bridgeway Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Bridgeway Capital Management held 1,507 positions worth $9.85B, up 5.8% from $9.31B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Bridgeway Capital Management deployed $305M of net new capital in Q2 2018, opening 131 new positions and adding to 296 existing holdings. Its largest new stake was Morgan Stanley: 1,333,400 shares worth $63.2M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Lam Research, an estimated $70.2M trimmed.

  • Bridgeway Capital Management's largest Q2 2018 buy was Morgan Stanley: 1,333,400 shares worth $63.2M.
  • Bridgeway Capital Management added most to Cigna in Q2 2018, an estimated $58.3M increase.
  • Bridgeway Capital Management's biggest Q2 2018 reduction was Lam Research, cutting an estimated $70.2M.
  • Bridgeway Capital Management fully exited Sempra in Q2 2018, selling an estimated $62.5M.
  • Bridgeway Capital Management's ten largest holdings make up 11% of its $9.85B portfolio in Q2 2018.
  • Bridgeway Capital Management opened 131 new positions and closed 100 in Q2 2018.
  • Bridgeway Capital Management's portfolio value rose 5.8% quarter-over-quarter to $9.85B.

Based on Bridgeway Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.